Health Canada has faced backlash over its continued endorsement and authorization of mRNA COVID-19 vaccines, despite the recent revelation that Pfizer withheld key information about the presence of residual DNA plasmids in the shots. The federal regulatory agency confirmed the existence of at least one previously undisclosed DNA plasmid, known as the SV40 promoter, following an investigation by journalist Matthew Horwood at the Epoch Times.
The revelation of the SV40 promoter has sparked controversy within the scientific integrity community, leading some to dub it “#PlasmidGate.” Experts have expressed concerns about the potential risks associated with injecting high levels of SV40 promoters into individuals. There is a risk that these promoters could integrate into the genome and promote the expression of genes inappropriately, potentially leading to health issues such as cancer.
Health Canada admitted that manufacturers are supposed to disclose all the ingredients of vaccines, including DNA sequences like the SV40 enhancer. However, Pfizer failed to disclose this information, and it was only after independent scientists discovered the presence of the SV40 promoter that Health Canada acknowledged its existence.
The safety implications of the SV40 promoter are still a topic of debate among experts. Dr. Phillip Buckhaults, a cancer genomics professor at the University of South Carolina, has argued that while the SV40 enhancer poses a small cancer hazard, all pieces of plasmid DNA present in the vaccines have some level of risk. In a recent testimony before a South Carolina senate medical committee, Buckhaults urged regulators to compel Pfizer to remove the DNA from their shots.
Despite the confirmation of the SV40 promoter, Health Canada’s risk-benefit analysis remains unchanged. However, Matthew Horwood emphasizes the need for further research to fully understand the long-term impacts of these vaccines. He believes that the concerns about potential cancer risks warrant a closer examination and suggests that a moratorium should have been called for shortly after the vaccines were released and cases of myocarditis in young men began to emerge.
Adding to the concerns about mRNA vaccines, a pre-print paper was recently published highlighting evidence of undisclosed DNA contamination in both Pfizer and Moderna’s vaccines. The paper raises serious safety and efficacy concerns and further supports the need for more research.
In conclusion, the news article reveals the undisclosed presence of residual DNA plasmids in Pfizer’s mRNA COVID-19 vaccines. Health Canada has acknowledged this discrepancy but has not altered its endorsement of the vaccines. Experts are divided on the safety implications of the SV40 promoter, but there is a growing call for more research and a reevaluation of the long-term impacts of these vaccines.